Key result
Radioiodine therapy successfully ablates port-site implanted tissue after robotic thyroidectomy with normal 7-year follow-up.
Why the study?
Robotic thyroidectomy via remote access can cause complications linked to the large working space required, which can lead to unusual imaging findings.
Case Report (n=1)
Port-site seeding after robotic thyroidectomy is a rare complication that can be successfully treated with a therapeutic dose of radioiodine.
May support radioiodine for rare port-site seeding after robotic thyroidectomy; leaves open need for larger studies on incidence and management.
BACKGROUND Robotic thyroidectomy using remote access approaches is currently regarded as the optimal surgical protocol for highly selected patients. This approach has excellent cosmetic outcomes compared with conventional open transcervical thyroidectomy. Although the remote access approach offers significant benefits, it can cause complications associated with the large working space required for surgery. Such complications can lead to unusual imaging findings. CASE REPORT We report a case of a 37-year-old woman with thyroid cancer who underwent robotic thyroidectomy and demonstrated unusual port-site implantation findings on post-treatment iodine-131 whole-body scintigraphy and single-photon emission computed tomography-computed tomography. Evaluation of stimulated thyroglobulin and additional imaging studies did not reveal any remarkable findings. Through a multidisciplinary discussion, we discovered that the bag had developed a tear during specimen retrieval. Our patient was administered a therapeutic dose of radioiodine, which accumulated within the target area and successfully ablated the implanted tissue. Follow-up imaging and biochemical studies were normal after a follow-up period of 7 years. CONCLUSIONS Port-site seeding is a rare and unexpected surgical complication; however, it can be treated with radioiodine therapy involving a therapeutic dose. Meticulous surgical manipulation is essential to prevent port-site implantation related to spillage and tearing of thyroid or cancer tissue. Awareness and identification of these rare complications, which manifest as unusual imaging findings, are critical for improving the accuracy of interpretation.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2019) conducted a case report in Thyroid cancer (n=1). Radioiodine therapy was evaluated on Ablation of implanted tissue. Radioiodine therapy successfully ablated port-site implanted tissue following robotic thyroidectomy, with normal imaging and biochemical studies after 7 years of follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: